Genovese, Giannicola
The University of Texas MD Anderson Cancer Center
9 papers on CoChatORCID 0000-0003-1392-9954
Most cited papers
- Verified
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell
Glioma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 5,016
- Verified
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell
Melanoma and MAPK PathwaysCutaneous Melanoma Detection and Management
Cited by 3,151
- Verified
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature
Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and Metabolism
Cited by 1,259
- Verified
Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma
Kwong, L. N., Costello, J. C., Liu, H., Jiang, S., Helms, T. L., Langsdorf, A. E., Jakubosky, D., Genovese, G., Muller, F. L., Jeong, J. H., et al. (2012) · Nature Medicine
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 358
- Verified
Passenger deletions generate therapeutic vulnerabilities in cancer
Muller, F. L., Colla, S., Aquilanti, E., Manzo, V. E., Genovese, G., Lee, J., Eisenson, D., Narurkar, R., Deng, P., Nezi, L., et al. (2012) · Nature
Cancer Genomics and DiagnosticsGlioma Diagnosis and Treatment
Cited by 339
- Verified
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
Dey, P., Baddour, J., Muller, F., Wu, C. C., Wang, H., Liao, W.-T., Lan, Z., Chen, A., Gutschner, T., Kang, Y., et al. (2017) · Nature
Cancer, Hypoxia, and MetabolismPancreatic and Hepatic Oncology Research
Cited by 264
- Verified
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
Dey, P., Li, J., Zhang, J., Chaurasiya, S., Strom, A., Wang, H., Liao, W.-T., Cavallaro, F., Denz, P., Bernard, V., et al. (2020) · Cancer Discovery
Pancreatic and Hepatic Oncology ResearchCytokine Signaling Pathways and Interactions
Cited by 213
- Verified
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
Genovese, G., Carugo, A., Tepper, J., Robinson, F. S., Li, L., Svelto, M., Nezi, L., Corti, D., Minelli, R., Pettazzoni, P., et al. (2017) · Nature
Pancreatic and Hepatic Oncology ResearchCancer Cells and Metastasis
Cited by 131
- Verified
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome
Colla, S., Ong, D. S. T., Ogoti, Y., Marchesini, M., Mistry, N. A., Clise-Dwyer, K., Ang, S. A., Storti, P., Viale, A., Giuliani, N., et al. (2015) · Cancer Cell
Telomeres, Telomerase, and SenescenceAcute Myeloid Leukemia Research
Cited by 105
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free